Compare Cronos Group Inc (CRON) vs TeraWulf Inc (WULF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs TeraWulf Inc — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while TeraWulf Inc trades at $13.96 (market cap $7.19B). The key difference: TeraWulf Inc is far larger — about 6× Cronos Group Inc's market cap, and Cronos Group Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and TeraWulf Inc for 17 Days on average.
| CRON | WULF | |
|---|---|---|
Market Cap | $1.20B | $7.19B |
Volume | 450,387 | 27,440,950 |
Sector | Health | Financials |
52-Week High | $3.55 | $28.98 |
52-Week Low | $2.30 | $10.99 |
Typical Hold Time | 22 Days | 17 Days |
Enterprise Value | $401.73M | $9.80B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.
Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.
WULF trades at $14.40, down 3.81% on the day, amid a volatile period for AI infrastructure stocks. The company shows strong analyst support with 14 buy ratings and a consensus price target of $34.92, but fundamentals reveal challenges: revenue of $168.46M in 2025 was overshadowed by a net loss of -$661.42M, resulting in negative profit margins. Recent news highlights the company's pivot to AI data center hosting, with UBS initiating bullish coverage citing constrained compute supply (UBS, September 23, 2026).
The outlook is bifurcated: analyst optimism contrasts with weak profitability and bearish technical signals. Investment opportunity lies in the AI hosting transition, but risks include persistent losses, high debt-to-asset ratio of 78.84%, and sector volatility. The stock's current price near key support at $14 suggests cautious sentiment despite long-term growth potential in AI infrastructure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About TeraWulf Inc
TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →
